Claudia Marchetti

11PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targetsObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer.

Claudia Marchetti, Gwenael Ferron, Olivier Colomban

|Nov 04, 2025
Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacy.

Adriana Ionelia Apostol, Matteo Bruno, Carolina Maria Sassu

|Jun 10, 2024
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients.

Matteo Bruno, Adriana Ionelia Apostol, Serena Maria Boccia

|May 28, 2024
Epithelial ovarian cancer and brain metastases: might the <i>BRCA</i> status, PARP inhibitor administration, and surgical treatment impact the survival?

Carolina Maria Sassu, Claudia Marchetti, Giorgia Russo

|Apr 20, 2024
Medicolegal and insurance issues regarding <i>BRCA1</i> and <i>BRCA2</i> gene tests in high income countries.

Riccardo Oliva, Simone Grassi, Claudia Marchetti

|Mar 04, 2024
New windows of surgical opportunity for gynecological cancers in the era of targeted therapies.

Inge Peters, Claudia Marchetti, Giovanni Scambia

Pageof 2